CVM GFI #259 (VICH GL58) Stability Testing of New Veterinary Drug Substances and Medicinal Products in Climatic Zones III and IV
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
April 14, 2020
April 13, 2020
beee0208-1df9-4294-a967-d9dd2a544b7c
Related Documents
CVM GFI #267 Biomarkers and Surrogate Endpoints in Clinical Studies to Support Effectiveness of New Animal Drugs
Guidance DocumentOctober 6, 2021Center for Veterinary Medicine
CVM GFI #255 Elemental Impurities in Animal Drug Products Questions and Answers
Guidance DocumentNovember 23, 2020Center for Veterinary Medicine
CVM GFI #242 In-Use Stability Studies and Associated Labeling Statements for Multiple-Dose Injectable Animal Drug Products
Guidance DocumentNovember 27, 2020Center for Veterinary Medicine
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.